Morr F 5% Topical Solution for Effective Androgenetic Alopecia Treatment
| Product dosage: 60 ml | |||
|---|---|---|---|
| Package (num) | Per sprayer | Price | Buy |
| 1 | $86.00 | $86.00 (0%) | 🛒 Add to cart |
| 2 | $70.95 | $172.00 $141.90 (17%) | 🛒 Add to cart |
| 3 | $63.07 | $258.00 $189.20 (27%) | 🛒 Add to cart |
| 4 | $59.12 | $344.00 $236.50 (31%) | 🛒 Add to cart |
| 5 | $52.80
Best per sprayer | $430.00 $264.02 (39%) | 🛒 Add to cart |
Morr F 5% topical solution is a clinically-formulated treatment designed for the management of androgenetic alopecia (pattern hair loss) in both men and women. Combining minoxidil 5% and finasteride 0.1% in a synergistic, alcohol-based vehicle, this dual-action solution targets the underlying hormonal and vascular mechanisms of hair loss. It is intended for topical application to the scalp to promote hair regrowth, increase hair density, and slow further progression of balding. This product requires consistent use and is most effective when initiated in the early stages of hair thinning.
Features
- Contains minoxidil 5% and finasteride 0.1% in a single formulation
- Alcohol-based solution for enhanced cutaneous absorption
- Applied topically once or twice daily
- Supplied in 60mL bottles with graduated dropper
- Preservative-stabilized for shelf life and user safety
- Designed for application to dry scalp only
Benefits
- Promotes visible hair regrowth in androgen-dependent alopecia
- Reduces scalp dihydrotestosterone (DHT) levels through local finasteride action
- Increases blood flow to hair follicles via minoxidil-induced vasodilation
- Slows further hair miniaturization and loss
- Non-invasive alternative to oral finasteride in selected cases
- May improve overall hair thickness and coverage over time
Common use
Morr F is indicated for the treatment of male and female pattern hair loss (androgenetic alopecia). It is most commonly used by adult patients experiencing gradual thinning at the crown or frontal scalp. The solution is applied directly to affected areas of the scalp. Patients typically begin to observe reduced hair shedding within 2–3 months, with visible regrowth often apparent after 4–6 months of consistent use. Long-term application is generally required to maintain results.
Dosage and direction
Apply 1mL of Morr F solution directly to the dry scalp in the affected area(s) once or twice daily, as directed by a healthcare provider. Using the provided dropper, part the hair to expose the scalp and apply the solution evenly. Wash hands thoroughly after application. Do not apply to other areas of the body. Allow the solution to dry completely before styling hair, using hats, or going to bed. Do not shampoo for at least four hours after application.
Precautions
Avoid contact with eyes, mucous membranes, and broken or irritated skin. Do not use with other topical scalp products unless advised by a physician. Women who are pregnant, planning pregnancy, or breastfeeding should not handle this product due to potential finasteride exposure. Discontinue use and consult a healthcare provider if scalp irritation, redness, or itching persists. Keep out of reach of children and pets.
Contraindications
Hypersensitivity to minoxidil, finasteride, or any component of the formulation. Not for use by women who are pregnant or may become pregnant. Do not use on individuals under 18 years of age. Avoid in patients with cardiovascular disease, especially those with hypotension or arrhythmias, unless supervised by a physician. Not recommended for use in patients with history of adverse reactions to 5-alpha-reductase inhibitors.
Possible side effects
Common side effects may include mild scalp itching, dryness, flaking, or redness. Some users may experience temporary increased hair shedding during the first few weeks of treatment. Less frequently, users may report dizziness, headache, or local irritation. Systemic absorption of finasteride may rarely lead to sexual side effects such as decreased libido or erectile dysfunction. If adverse effects are severe or persistent, discontinue use and seek medical advice.
Drug interaction
Potential interactions may occur with other topical agents applied to the scalp. Concurrent use of oral finasteride is not recommended due to risk of compounded anti-androgenic effects. Use caution with antihypertensive medications due to minoxidil’s vasodilatory effects. Consult a physician before using with other DHT-blocking agents, hormonal therapies, or topical corticosteroids.
Missed dose
If a dose is missed, apply as soon as remembered. If it is nearly time for the next dose, skip the missed dose and resume the regular schedule. Do not apply extra solution to compensate for a missed dose.
Overdose
Topical overdose may result in systemic effects such as hypotension, tachycardia, dizziness, or syncope. If accidental ingestion occurs, seek immediate medical attention. Excessive topical application may lead to severe scalp irritation or systemic absorption. In case of suspected overdose, contact a poison control center or emergency room.
Storage
Store at room temperature (15–30°C). Keep the bottle tightly closed and protected from light. Do not freeze. Keep away from heat and open flame. Discard any unused solution 30 days after opening. Do not transfer to other containers.
Disclaimer
This product is for topical use only. It is not a cure for baldness and results may vary. Use under medical supervision. Read instructions carefully before use. Not evaluated or approved for use by the FDA in this combined formulation in all regions. Consult a healthcare professional before starting treatment, especially if you have underlying medical conditions.
Reviews
Clinical studies and user reports indicate that Morr F can be effective in stabilizing hair loss and promoting regrowth in a significant proportion of users. Many patients note a reduction in shedding after 8–12 weeks and improved coverage after 6 months. Some users report mild initial irritation that often resolves with continued use. Adherence to daily application is critical for optimal outcomes. Individual results may vary based on extent of hair loss, duration of condition, and consistency of use.